4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-005385
Options or other derivatives
- Chief Medical Officer acquired 475,831 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arbet-Engels Christophe Chief Medical Officer | 2024-02-13 | Grant or award · Stock Appreciation Right | +475,831 | 475,831 | D | ||
Loading xslF345X05/wk-form4_1708121451.xml…